Finland· FI-REL-REL5862
Erco-Fer
A ferrous fumarate product, registered in Finland by Orion Pharma A/S. The same ATC class is registered in 5 of our 19 countries.
Checked against Fimea (Finland) on
Informational only — not a medical device.
Where it is registered
Ferrous fumarate is registered in 5 of 19 countries.
Countries holding a registration under ATC B03AA02 (ferrous fumarate), each read from that country’s own register.
- This record: Finland, from Fimea (Finland)
- 2 of them publish a price we can compare per daily dose
Ferrous fumarate · ATC B03AA02
5 / 19 countries
- Denmark
- Finlandprice
- Ireland
- Netherlands
- Switzerlandprice
Price per daily dose
What a daily dose of ferrous fumarate costs, country by country.
Normalised to the WHO defined daily dose (0.2 g), so markets compare like for like.
- 1 market with a comparable price for this class
- Public list prices, converted to USD at the rate date shown
Ferrous fumarate · price per daily dose (0.2 g)
USD · FX 28 Sept 2026
- CH Switzerland$0.62
The record
At a glance
Fimea (Finland)- Manufacturer
- Orion Pharma A/S
- Country
- Finland (FI)
- ATC code
- B03AA02
- ATC class
- Ferrous fumarate
- Defined daily dose
- 0.2 g, O
- Reimbursed
- Not published by this register
- Source register
- Fimea (Finland)
- Last checked
- September 27, 2026
Packs & prices · 0
No packs listed by the register for this record.
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
89 interactions on record for ferrous fumarate.
Graded by severity as the source publishes them — 3 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Ferrous fumarate · interactions on record
89 records
- 3 severe
- 69 moderate
- 7 minor
Most severe, free to view
- DolutegravirJ05AJ03severe
- DolutegravirJ05AX12severe
- DimercaprolV03AB09severe
- Magnesium carbonateA02AA01moderate
10 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same class
Other records under B03AA02
Ferrous fumarate, as other registers publish it.
- FinlandFerpolarOrion Corporation Orion Pharma
- FinlandFerpolarOrion Corporation Orion Pharma
- NetherlandsFerrofumaraat Auro 200 mg, filmomhulde tablettenAurobindo Pharma B.V.
- NetherlandsFerrofumaraat CF 200 mg, tablettenCentrafarm B.V.
- NetherlandsFerrofumaraat Teva 100 mg, filmomhulde tablettenTeva Nederland B.V.
- NetherlandsFerrofumaraat Teva 20 mg/ml, suspensieTeva Nederland B.V.
- NetherlandsFerrofumaraat Teva 200 mg, omhulde tablettenTeva Nederland B.V.
- SwitzerlandFerrum Hausmann
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Fimea (Finland). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f6b3fbd2-10bb-450c-a9b9-bb85d5872e9b GET /v1/drugs/f6b3fbd2-10bb-450c-a9b9-bb85d5872e9b?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"ddd": "0.2",
"form": "tabletti",
"route": null,
"ddd_unit": "g",
"strength": "60 mg Fe++",
"atc_label": "ferrofumaraatti",
"ma_number": "559",
"auth_status": "Myyntilupa peruuntunut",
"eu_ma_number": null,
"fimea_rel_id": "REL5862",
"authorised_at": "1964-11-25"
}See everything about ferrous fumarate.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.